2 options
Examining patient access to investigational drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session. October 3, 2017.
- Format:
- Book
- Government document
- Author/Creator:
- United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author.
- Language:
- English
- Subjects (All):
- United States. Food and Drug Administration.
- United States.
- Clinical trials--United States.
- Clinical trials.
- Clinical trials--Moral and ethical aspects--United States.
- Drugs--United States--Testing.
- Drugs.
- Drugs--Testing--Moral and ethical aspects--United States.
- Clinical trials--Moral and ethical aspects.
- Drugs--Testing.
- Drugs--Testing--Moral and ethical aspects.
- Genre:
- Online resources.
- Legislative hearings
- Legislative hearings.
- Physical Description:
- 1 online resource (iv, 235 pages) : photographs
- Place of Publication:
- Washington : U.S. Government Publishing Office, 2018.
- Notes:
- Description based on online resource, PDF version; title from title page (govinfo, viewed Dec. 27, 2018).
- Includes bibliographical references.
- "Serial No. 115-60."
- Other Format:
- Microfiche version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Examining patient access to investigational drugs
- Print version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Examining patient access to investigational drugs
- OCLC:
- 1080339765
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.